483
Icrom SpaIcrom Spa – FDA 483, Mar 18, 2019
Record Details
An FDA inspection of Icrom S.p.A, an API manufacturer in Concorezzo, Italy, revealed 10 observations concerning significant deficiencies in their manufacturing and quality control systems. Key issues included inadequate cleaning procedures, lack of proper quality unit oversight, poor documentation practices, and insufficient investigation of discrepancies. These findings indicate a potential risk to product quality and purity due to a lack of robust controls.
View Company Profile
ID · b760db23-c026-43f3-8869-e098a0ad8b1c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.